About Pernix

Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, and development of branded pharmaceutical products. The Company markets a portfolio of branded products, including: SILENOR®, a non-narcotic product for the treatment of insomnia, and KHEDEZLA™, as well as CEDAX®, an antibiotic for middle ear infections and a number of treatments for cough and cold conditions including ZUTRIPRO®, REZIRA® and VITUZ®. The Company promotes its branded products to physicians through its Pernix sales force and markets its generic portfolio through its wholly owned subsidiaries, Cypress Pharmaceuticals and Macoven Pharmaceuticals. Founded in 1996, the Company is now based in Morristown, New Jersey.

Management

  • Douglas L. Drysdale
    Chairman, President and Chief Executive Officer
    Mr. Drysdale served as Chief Executive...
  • Terence Novak
    Chief Operating Officer
    Mr. Novak most recently served as President of Norwich...
  • Sanjay Patel
    Chief Financial Officer
    Mr. Patel brings to Pernix over 15 years of...
  • Rick Shalaby
    Senior Vice President of Sales and Marketing
    Mr. Shalaby brings over twenty-three...
read more